Resources

PATH has been contributing to Nepal's health care transformation since 2014. PATH partners with governments and local organizations to strengthen health systems by addressing inequities in key health areas—vaccines and immunization, neglected tropical diseases, digital health, maternal, newborn, child health and nutrition, and disease surveillance.

PATH works to strengthen health equity through increased access to gender-responsive health services and innovations. Read this factsheet to learn more about our work in this area.

Medical devices are critical for detecting and treating many serious health conditions facing mothers and newborns, including anemia, pre-eclampsia, and neonatal respiratory distress. They also have expensive and complex training and maintenance needs and are thus challenging to manage effectively in low resource settings. However, there is a lack of systematic, cross-country, and cross-device data outlining these challenges and evaluating current device access.PATH led the Market Dynamics for Medical Devices (MD4MD) project to address this need, quantifying device availability and diagnosing key barriers to access for five priority countries and seven priority maternal, newborn, and child health (MNCH) devices. This report aims to summarize key findings from this research and outline an investment agenda for improving access to these critical devices.

The Global Fund to Fight AIDS, Tuberculosis and Malaria is a worldwide movement to defeat HIV, tuberculosis (TB), and malaria and ensure a healthier, safer, more equitable future for all. They raise and invest US$4 billion a year to fight the deadliest infectious diseases, challenge the injustice that fuels them, and strengthen health systems in more than 100 countries.In recent years, the Global Fund has emerged as an important source of funding for respiratory care equipment, supplies, and services for low- and middle-income countries—with the COVID-19 Response Mechanism (C19RM), and more recently, via the inclusion of respiratory care equipment as a new allowable Resilient and Sustainable Systems for Health (RSSH) intervention.This brief outlines key information and resources for pursuing funding for oxygen and respiratory care systems through the Global Fund via the C19RM and country grants. It is intended for use by applicants, partners, civil society, and others in developing funding requests and/or advocating for prioritization of respiratory care goods and services in Global Fund grants.

PATH initiated an intervention study, A Mixed-Method Study to Improve the Outcome of Mass Drug Administration in Two Districts of Uttar Pradesh That Failed the Transmission Assessment Survey. The study aims to identify the critical factors for achieving optimal drug coverage amongst community members during mass drug administration (MDA) campaigns, develop an intervention package for use in the government’s subsequent MDA programme to improve compliance, and assess the impact of the intervention package on drug coverage.The study was conducted in the districts of Varanasi and Chitrakoot in Uttar Pradesh, as they failed Transmission Assessment Surveys (TASs), have suboptimal health indicators, and are geographically and demographically representative of districts that are lymphatic filariasis (LF) endemic in the country.The report shares the key findings and assesses the impact of the intervention package on reach and consumption of LF drugs during MDA rounds.